{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:24:15Z","timestamp":1786940655506,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"LOA IV fund, managed by curafutura, pharmaSuisse and sant\u00e9suisse","award":["00"],"award-info":[{"award-number":["00"]}]},{"name":"P&G Health, UCB, Tilman, Sanofi, Almirall, Ceres Pharma, Effik and Johnson & Johnson"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04925-z","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:52:56Z","timestamp":1781153576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort"],"prefix":"10.1186","volume":"26","author":[{"given":"Eva","family":"Gerbier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Oppliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemanjari","family":"Kandhasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Winterfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Legardeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spoendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Panchaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"1","key":"4925_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(19)30333-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"4925_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.crohns.2014.02.015","volume":"8","author":"A Jussila","year":"2014","unstructured":"Jussila A, Virta LJ, Pukkala E, F\u00e4rkkil\u00e4 MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8(9):1088\u201396. https:\/\/doi.org\/10.1016\/j.crohns.2014.02.015.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4925_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/apt.16615","volume":"55","author":"J Burisch","year":"2022","unstructured":"Burisch J, Lophaven S, Langholz E, Munkholm P. The clinical course of Crohn\u2019s disease in a Danish population-based inception cohort with more than 50\u00a0years of follow-up, 1962-2017. Aliment Pharmacol Ther. 2022;55(1):73\u201382. https:\/\/doi.org\/10.1111\/apt.16615.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"4925_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2036.2010.04234.x","volume":"31","author":"RD Cohen","year":"2010","unstructured":"Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010;31(7):693\u2013707. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04234.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10114","key":"4925_CR5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0.","journal-title":"Lancet"},{"key":"4925_CR6","unstructured":"Maladies inflammatoires chroniques de l\u2019intestin (MICI) \u22c5 Inserm, La science pour la sant\u00e9. Inserm. https:\/\/www.inserm.fr\/dossier\/maladies-inflammatoires-chroniques-intestin-mici\/. Accessed 26 Jan 2023."},{"issue":"suppl_2","key":"4925_CR7","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/ibd.20545","volume":"14","author":"RD Johnston","year":"2008","unstructured":"Johnston RD, Logan RFA. What is the peak age for onset of IBD? Inflamm Bowel Dis. 2008;14(suppl_2):S4\u20135. https:\/\/doi.org\/10.1002\/ibd.20545.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"4925_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.crohns.2012.04.009","volume":"6","author":"S Vermeire","year":"2012","unstructured":"Vermeire S, Carbonnel F, Coulie PG, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012;6(8):811\u201323. https:\/\/doi.org\/10.1016\/j.crohns.2012.04.009.","journal-title":"J Crohns Colitis"},{"key":"4925_CR9","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/j.1572-0241.1998.00698.x","volume":"93","author":"K Fonager","year":"1998","unstructured":"Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn\u2019s disease a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426\u201330.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"4925_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gut.2006.108324","volume":"56","author":"J Cornish","year":"2007","unstructured":"Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56(6):830\u20137. https:\/\/doi.org\/10.1136\/gut.2006.108324.","journal-title":"Gut"},{"issue":"9","key":"4925_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/j.1572-0241.2007.01355.x","volume":"102","author":"B N\u00f8rg\u00e5rd","year":"2007","unstructured":"N\u00f8rg\u00e5rd B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn\u2019s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102(9):1947\u201354. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01355.x.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 1","key":"4925_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000506364","volume":"101","author":"MC Sulz","year":"2020","unstructured":"Sulz MC, Burri E, Michetti P, et al. Treatment algorithms for Crohn\u2019s disease. Digestion. 2020;101(Suppl. 1):43\u201357. https:\/\/doi.org\/10.1159\/000506364.","journal-title":"Digestion"},{"issue":"Suppl. 1","key":"4925_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000504092","volume":"101","author":"E Burri","year":"2020","unstructured":"Burri E, Maillard MH, Schoepfer AM, et al. Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update. Digestion. 2020;101(Suppl. 1):2\u201315. https:\/\/doi.org\/10.1159\/000504092.","journal-title":"Digestion"},{"issue":"Suppl 1","key":"4925_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000502886","volume":"101","author":"S Restellini","year":"2020","unstructured":"Restellini S, Biedermann L, Hruz P, et al. Update on the management of inflammatory bowel disease during pregnancy and breastfeeding. Digestion. 2020;101(Suppl 1):27\u201342. https:\/\/doi.org\/10.1159\/000502886.","journal-title":"Digestion"},{"issue":"Suppl 3","key":"4925_CR15","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1\u2013106. https:\/\/doi.org\/10.1136\/gutjnl-2019-318484.","journal-title":"Gut"},{"issue":"1","key":"4925_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","volume":"4","author":"A Dignass","year":"2010","unstructured":"Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: current management. J Crohns Colitis. 2010;4(1):28\u201362. https:\/\/doi.org\/10.1016\/j.crohns.2009.12.002.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"4925_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Seow CH, Maxwell C, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150(3):734-757.e1. https:\/\/doi.org\/10.1053\/j.gastro.2015.12.003.","journal-title":"Gastroenterology"},{"issue":"6","key":"4925_CR18","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010","volume":"7","author":"CP Selinger","year":"2013","unstructured":"Selinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7(6):e206\u201313. https:\/\/doi.org\/10.1016\/j.crohns.2012.09.010.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"4925_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/ecco-jcc\/jjw011","volume":"10","author":"P Ellul","year":"2016","unstructured":"Ellul P, Zammit SC, Katsanos KH, et al. Perception of reproductive health in women with inflammatory bowel disease. J Crohns Colitis. 2016;10(8):886\u201391. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw011.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"4925_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.crohns.2009.10.001","volume":"4","author":"RE Mountifield","year":"2010","unstructured":"Mountifield RE, Prosser R, Bampton P, Muller K, Andrews JM. Pregnancy and IBD treatment: this challenging interplay from a patients\u2019 perspective. J Crohns Colitis. 2010;4(2):176\u201382. https:\/\/doi.org\/10.1016\/j.crohns.2009.10.001.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"4925_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/ibd\/izaa294","volume":"27","author":"G Br\u00f6ms","year":"2021","unstructured":"Br\u00f6ms G, Friedman S, Kim SC, et al. The patterns of use of medications for inflammatory bowel disease during pregnancy in the US and Sweden are changing. Inflamm Bowel Dis. 2021;27(9):1427\u201334. https:\/\/doi.org\/10.1093\/ibd\/izaa294.","journal-title":"Inflamm Bowel Dis"},{"key":"4925_CR22","doi-asserted-by":"publisher","first-page":"4105993","DOI":"10.1155\/2023\/4105993","volume":"2023","author":"E Gerbier","year":"2023","unstructured":"Gerbier E, Favre G, Maisonneuve E, et al. Antidiabetic medication utilisation before and during pregnancy in Switzerland between 2012 and 2019: an administrative claim database from the MAMA cohort. J Diabetes Res. 2023;2023:4105993. https:\/\/doi.org\/10.1155\/2023\/4105993.","journal-title":"J Diabetes Res"},{"key":"4925_CR23","unstructured":"Rapport de gestion. https:\/\/www.css.ch\/fr\/a-propos-de-css\/portrait\/medias-publications\/rapport-gestion.html. Accessed 2 Aug 2022."},{"issue":"3","key":"4925_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/ijerph19031456","volume":"19","author":"E Gerbier","year":"2022","unstructured":"Gerbier E, Graber SM, Rauch M, et al. Use of prescribed drugs to treat chronic diseases during pregnancy in outpatient care in Switzerland between 2014 and 2018: descriptive analysis of Swiss health care claims data. Int J Environ Res Public Health. 2022;19(3):1456. https:\/\/doi.org\/10.3390\/ijerph19031456.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4925_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/pds.3284","volume":"22","author":"AV Margulis","year":"2013","unstructured":"Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hern\u00e1ndez-D\u00edaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16\u201324. https:\/\/doi.org\/10.1002\/pds.3284.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4925_CR26","doi-asserted-by":"publisher","first-page":"w30048","DOI":"10.4414\/smw.2021.w30048","volume":"151","author":"E Gerbier","year":"2021","unstructured":"Gerbier E, Graber SM, Rauch M, et al. Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data. Swiss Med Wkly. 2021;151:w30048. https:\/\/doi.org\/10.4414\/smw.2021.w30048.","journal-title":"Swiss Med Wkly"},{"key":"4925_CR27","doi-asserted-by":"publisher","first-page":"w20386","DOI":"10.4414\/smw.2021.20386","volume":"151","author":"J Spoendlin","year":"2021","unstructured":"Spoendlin J, Blozik E, Graber SM, et al. Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data. Swiss Med Wkly. 2021;151:w20386. https:\/\/doi.org\/10.4414\/smw.2021.20386.","journal-title":"Swiss Med Wkly"},{"key":"4925_CR28","unstructured":"Office f\u00e9d\u00e9ral de la statistique. Nombre et taux de c\u00e9sariennes selon le canton\u00a0et la r\u00e9gion de domicile - 2007\u20132019 | Tableau. In: Office f\u00e9d\u00e9ral de la statistique. 2020.\u00a0https:\/\/www.bfs.admin.ch\/asset\/fr\/14841442. Accessed 2 Aug 2022."},{"key":"4925_CR29","unstructured":"Office f\u00e9d\u00e9ral de la statistique. Age moyen des m\u00e8res et des p\u00e8res \u00e0 la naissance de l\u2019enfant selon la cat\u00e9gorie de nationalit\u00e9, de 1971 \u00e0 2020 - 1971\u20132020 | Tableau. In: Office f\u00e9d\u00e9ral de la statistique. 2021.\u00a0https:\/\/www.bfs.admin.ch\/asset\/fr\/18845655. Accessed 2 Aug 2022."},{"issue":"4","key":"4925_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113(4):481. https:\/\/doi.org\/10.1038\/ajg.2018.27.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"4925_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.crohns.2007.10.006","volume":"2","author":"P Juillerat","year":"2008","unstructured":"Juillerat P, Pittet V, Bulliard JL, et al. Prevalence of inflammatory bowel disease in the Canton of Vaud (Switzerland): a population-based cohort study. J Crohns Colitis. 2008;2(2):131\u201341. https:\/\/doi.org\/10.1016\/j.crohns.2007.10.006.","journal-title":"J Crohns Colitis"},{"issue":"7","key":"4925_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.cgh.2019.08.031","volume":"18","author":"S Friedman","year":"2020","unstructured":"Friedman S, Nielsen J, N\u00f8hr EA, J\u00f8lving LR, N\u00f8rg\u00e5rd BM. Comparison of time to pregnancy in women with and without inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18(7):1537-1544.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.08.031.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"30","key":"4925_CR33","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3748\/wjg.v28.i30.4102","volume":"28","author":"LY Yao","year":"2022","unstructured":"Yao LY, Shao BL, Tian F, et al. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2022;28(30):4102\u201319. https:\/\/doi.org\/10.3748\/wjg.v28.i30.4102.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4925_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/ibd\/izaa127","volume":"27","author":"M Noureldin","year":"2021","unstructured":"Noureldin M, Cohen-Mekelburg S, Mahmood A, et al. Trends of 5-Aminosalicylate medication use in patients with Crohn disease. Inflamm Bowel Dis. 2021;27(4):516. https:\/\/doi.org\/10.1093\/ibd\/izaa127.","journal-title":"Inflamm Bowel Dis"},{"key":"4925_CR35","doi-asserted-by":"crossref","unstructured":"Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979\u20132011 | Gut. https:\/\/gut.bmj.com\/content\/63\/10\/1607.long. Accessed 15 Feb 2023.","DOI":"10.1136\/gutjnl-2013-305607"},{"issue":"8","key":"4925_CR36","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/apt.12929","volume":"40","author":"AM Schoepfer","year":"2014","unstructured":"Schoepfer AM, Bortolotti M, Pittet V, et al. The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn\u2019s disease. Aliment Pharmacol Ther. 2014;40(8):930\u20137. https:\/\/doi.org\/10.1111\/apt.12929.","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl_2","key":"4925_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/ibd.20578","volume":"14","author":"JK Marshall","year":"2008","unstructured":"Marshall JK. Are there epidemiological differences between Crohn\u02bcs disease and Ulcerative colitis?: Inflamm Bowel Dis. 2008;14(suppl_2):S1. https:\/\/doi.org\/10.1002\/ibd.20578.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4925_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/ANS.0000000000000263","volume":"42","author":"M Beauchemin","year":"2019","unstructured":"Beauchemin M, Cohn E, Shelton RC. Implementation of clinical practice guidelines in the healthcare setting: a concept analysis. ANS Adv Nurs Sci. 2019;42(4):307\u201324. https:\/\/doi.org\/10.1097\/ANS.0000000000000263.","journal-title":"ANS Adv Nurs Sci"},{"issue":"2","key":"4925_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","volume":"77","author":"X Mariette","year":"2018","unstructured":"Mariette X, F\u00f6rger F, Abraham B, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228\u201333. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212196.","journal-title":"Ann Rheum Dis"},{"key":"4925_CR40","unstructured":"AIPS - Recherche individuelle. https:\/\/www.swissmedicinfo.ch\/ViewMonographie. Accessed 21 Aug 2023."},{"issue":"3","key":"4925_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.crohns.2009.11.005","volume":"4","author":"LKPM Brakenhoff","year":"2010","unstructured":"Brakenhoff LKPM, van der Heijde DM, Hommes DW, Huizinga TWJ, Fidder HH. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis. 2010;4(3):257\u201368. https:\/\/doi.org\/10.1016\/j.crohns.2009.11.005.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04925-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:27:22Z","timestamp":1786937242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04925-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4925"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04925-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3645136\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Since the dataset did not contain any identifiable personal information, consent to participate was not required. The ethics committee did not provide a waiver because anonymized secondary data do not fall under its review requirements.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was not required, because the study used anonymized secondary data and did not include any individual person\u2019s identifiable information.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"511"}}